Trial · NCT06807788
Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis
NCT06807788, Active not recruiting, Jose Carlos Nicolau
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis. Trials, record NCT06807788. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06807788
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis
- NCT number
- NCT06807788
- Status
- Active not recruiting
- Enrollment
- 100 participants, estimated
- Lead sponsor
- Jose Carlos Nicolau
- Conditions
- Takayasu Arteritis (TAK), Vasculitis, Systemic
- Interventions
- Clopidogrel
- First posted
- 2025-02-04
- Last updated
- 2025-02-04
Source ClinicalTrials.gov
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Platelet Aggregation analyzed by optical aggregometry-ADP (AggRAM™- Helena Laboratories) | 14 days | Compare platelet aggregation analyzed by optical aggregometry-ADP (AggRAM™- Helena Laboratórios) between both groups |
| Secondary | Platelet aggregability by AggRAM™ arachidonic acid at baseline; | Baseline | Avaliation of Platelet aggregability by AggRAM™ arachidonic acid at baseline |
| Secondary | Platelet aggregability by AggRAM™ ADP after 14 days of use of Clopidogrel 75 mg/day; | 14 days | Evaluation of Platelet aggregability by AggRAM™ ADP after 14 days of use of Clopidogrel 75 mg/day; |
| Secondary | Platelet aggregability by Plateletworks-ADP at baseline and after 14 days of use of Clopidogrel 75 mg/day | 14 days | Evaluation of Platelet aggregability by Plateletworks-ADP at baseline and after 14 days of use of Clopidogrel 75 mg/day; |
| Secondary | Serum levels of ultrasensitive C-reactive protein (hs-CRP); | Baseline | Avaliation of Serum levels of ultrasensitive C-reactive protein (hs-CRP) |
| Secondary | Serum levels of immature platelets; | Baseline | Evaluation of Serum levels of immature platelets |
| Secondary | Platelet count | Baseline | Evaluation of Platelet count; |
| Secondary | Serum levels of P-Selectin | Baseline | Evaluation of Serum levels of P-Selectin |
| Secondary | Serum levels of interleukin 6 | Baseline | Evaluation of Serum levels of interleukin 6; |
| Secondary | Serum levels of Interleukin 1 | Baseline | Evaluation of interleukin 1 |
1 to 10 of 22Source ClinicalTrials.gov
See all 22 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers17
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06807788
GET https://conductscience.org/api/trials/v1/NCT06807788/registered?page=2